100 participants
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-07-21
- Start Date:
- 2020-09-23
- Completion:
- 2022-07-11
Conditions
- Triple Negative Breast Cancer
Interventions
- DRUG
No Results Yet